Gapping up
Select metals/mining stocks trading higher:
- IAG +2.2%, GDX +1.8%, BHP +1.7%, GOLD +1.3%, GLD +1.2%, SLV +1.1%, NEM +1%, .
Other news:
- MNOV +50.5% (announces positive results from phase 2 trial of MN-166 in alcohol use disorder published in Nature's Translational Psychiatry Journal)
- RAVN +49.3% (Raven Industries to be acquired by CNHI for $58.00 per share)
- TRCH +40% (strength attributed to speculation on Reddit forums)
- ENOB +16.7% (acquires exclusive license for potential pan-coronavirus and pan-influenza inhaled treatment and prevention technology)
- RFL +8.4% (enters strategic merger with Rafael Pharmaceuticals)
- AVXL +7.7% (reports predictive biomarker of response established with SIGMAR1 mRNA expression correlates significantly with responses in primary clinical efficacy endpoints from the U.S. Phase 2 randomized, double-blind, placebo-controlled trial of ANAVEX2-73 in adult female patients with Rett syndrome)
- FULC +4.8% (Announces multiple presentations at the 28th Annual FSHD Society International Research Congress)
- ONE +4% (announced that Mr. Tuanwei Shi has tendered his resignation as chief technology officer due to personal reasons, effective June 17)
- TNXP +3.3% (announces program to develop TNX-102 SL for the treatment of long COVID syndrome, also known as post-acute sequelae of COVID-19)
- ALBO +2.6% (reports expanded Phase 3 data on Bylvay)
- AMBA +2.4% (announced the expansion of its AI vision SoC portfolio with the new CV5S and CV52S security families)
- VIR +2.1% (Vir Biotechnology and GSK (GSK) announce continuing progress of the COMET clinical development program for Sotrovimab)
- ARWR +1.6% (Arrowhead and Horizon Therapeutics (HZNP) collaborate to develop RNAi Therapeutic for uncontrolled gout)
- PSTH +1.3% (Pershing Square Tontine Holdings acquires 10% of Universal Music Group from Vivendi (VIVHY) for ~$4 bln)
- EGY +1.3% (appoints Ronald Bain as CFO)
- GME +1.3% (appoints Matt Furlong to the Company's Board of Directors effective immediately)
Analyst comments:
- FIGS +3.5% (initiated with an Outperform at Oppenheimer, among others)
- ZIP +3.2% (initiated with a Buy at Goldman)